Personally, and this is all just hypothetical and my own humble opinion, once CIAB is in the market and established as the leading therapy for pancreatic cancer I see it around 5-25$ a share.
Market cap is roughly 1 billion $ per dollar per share
After profits, the sky is the limit
Atm though I'm happy getting the IND and move on to trials